Adrenergic Drugs
Sympathomimetics & Adrenergic Antagonists — Receptors, Agents, Shock Therapy & Recent Advances
Past RGUHS + DNB + MPMSU + MUHS + VNSGU · 27
RGUHSMar '26
RGUHSSep '25
MPMSUJan '25
VNSGUJan '25
VNSGUSep '25
VNSGUJun '23
RGUHSNov '22
RGUHSMay '22
DNBJun '22
VNSGUApr '22
RGUHSNov '21
RGUHSJul '21
RGUHSJun '20
MUHSWinter '20
MPMSU2018
MPMSUMay '18
MPMSU2018
MUHSWinter '18
MUHSWinter '18
MPMSU2016
VNSGUApr '16
DNBDec '13
DNBDec '12
DNBDec '11
RGUHSMay '10
RGUHSSep '07
MPMSU2006
Introduction & terminology
- Adrenergic (sympathomimetic) drugs — mimic the actions of adrenaline or of sympathetic stimulation; antiadrenergic / adrenergic antagonist drugs block the receptor actions of catecholamines at α, β or both adrenoceptor classes.
- Three endogenous catecholamines — noradrenaline (NA) — transmitter at most postganglionic sympathetic terminals; adrenaline (Adr) — the adrenal-medullary hormone acting via its circulating concentration; dopamine (DA) — central transmitter (basal ganglia, CTZ) with a limited renal-vascular peripheral role.
- Isoprenaline — synthetic pure β agonist with negligible α action — the pharmacological tool used to define β responses; NA and Adr underpin the "fight-or-flight" response.
- Scope — drugs either mimic catecholamines, block their synthesis / release / reuptake, or antagonise them at adrenoceptors — the framework for this whole topic.
Continue reading
Adrenergic Drugs
PharmaNotes Pro · LAQ
Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.